Global Hydroxyprogesterone Caproate Injection Market Growth 2025-2031

Publication ID:

LPI01253663

Publication Date:

January 29, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Hydroxyprogesterone Caproate Injection market size is predicted to grow from US$ 265 million in 2025 to US$ 291 million in 2031; it is expected to grow at a CAGR of 1.6% from 2025 to 2031.
Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.
Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.
The 鈥淗ydroxyprogesterone Caproate Injection Industry Forecast鈥� looks at past sales and reviews total world Hydroxyprogesterone Caproate Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Hydroxyprogesterone Caproate Injection sales for 2025 through 2031. With Hydroxyprogesterone Caproate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hydroxyprogesterone Caproate Injection industry.
This Insight Report provides a comprehensive analysis of the global Hydroxyprogesterone Caproate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hydroxyprogesterone Caproate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Hydroxyprogesterone Caproate Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hydroxyprogesterone Caproate Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hydroxyprogesterone Caproate Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Hydroxyprogesterone Caproate Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
1 mL Injection(Including 1.1 mL)
5 mL Injection
Segmentation by Application:
Hospitals Injection
Clinics Injection
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AMAG Pharmaceuticals
Mcguff Pharmaceuticals Inc
Aspen Oss B.V
American Regent, Inc.
Mylan Institutional
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hydroxyprogesterone Caproate Injection market?
What factors are driving Hydroxyprogesterone Caproate Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hydroxyprogesterone Caproate Injection market opportunities vary by end market size?
How does Hydroxyprogesterone Caproate Injection break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hydroxyprogesterone Caproate Injection Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hydroxyprogesterone Caproate Injection by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hydroxyprogesterone Caproate Injection by Country/Region, 2020, 2024 & 2031
2.2 Hydroxyprogesterone Caproate Injection Segment by Type
2.2.1 1 mL Injection(Including 1.1 mL)
2.2.2 5 mL Injection
2.3 Hydroxyprogesterone Caproate Injection Sales by Type
2.3.1 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2020-2025)
2.3.2 Global Hydroxyprogesterone Caproate Injection Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hydroxyprogesterone Caproate Injection Sale Price by Type (2020-2025)
2.4 Hydroxyprogesterone Caproate Injection Segment by Application
2.4.1 Hospitals Injection
2.4.2 Clinics Injection
2.5 Hydroxyprogesterone Caproate Injection Sales by Application
2.5.1 Global Hydroxyprogesterone Caproate Injection Sale Market Share by Application (2020-2025)
2.5.2 Global Hydroxyprogesterone Caproate Injection Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hydroxyprogesterone Caproate Injection Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Hydroxyprogesterone Caproate Injection Breakdown Data by Company
3.1.1 Global Hydroxyprogesterone Caproate Injection Annual Sales by Company (2020-2025)
3.1.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2020-2025)
3.2 Global Hydroxyprogesterone Caproate Injection Annual Revenue by Company (2020-2025)
3.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Company (2020-2025)
3.2.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Company (2020-2025)
3.3 Global Hydroxyprogesterone Caproate Injection Sale Price by Company
3.4 Key Manufacturers Hydroxyprogesterone Caproate Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hydroxyprogesterone Caproate Injection Product Location Distribution
3.4.2 Players Hydroxyprogesterone Caproate Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Hydroxyprogesterone Caproate Injection by Geographic Region
4.1 World Historic Hydroxyprogesterone Caproate Injection Market Size by Geographic Region (2020-2025)
4.1.1 Global Hydroxyprogesterone Caproate Injection Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hydroxyprogesterone Caproate Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hydroxyprogesterone Caproate Injection Market Size by Country/Region (2020-2025)
4.2.1 Global Hydroxyprogesterone Caproate Injection Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hydroxyprogesterone Caproate Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hydroxyprogesterone Caproate Injection Sales Growth
4.4 APAC Hydroxyprogesterone Caproate Injection Sales Growth
4.5 Europe Hydroxyprogesterone Caproate Injection Sales Growth
4.6 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Growth
5 Americas
5.1 Americas Hydroxyprogesterone Caproate Injection Sales by Country
5.1.1 Americas Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025)
5.1.2 Americas Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025)
5.2 Americas Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
5.3 Americas Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hydroxyprogesterone Caproate Injection Sales by Region
6.1.1 APAC Hydroxyprogesterone Caproate Injection Sales by Region (2020-2025)
6.1.2 APAC Hydroxyprogesterone Caproate Injection Revenue by Region (2020-2025)
6.2 APAC Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
6.3 APAC Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hydroxyprogesterone Caproate Injection by Country
7.1.1 Europe Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025)
7.1.2 Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025)
7.2 Europe Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
7.3 Europe Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hydroxyprogesterone Caproate Injection by Country
8.1.1 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hydroxyprogesterone Caproate Injection
10.3 Manufacturing Process Analysis of Hydroxyprogesterone Caproate Injection
10.4 Industry Chain Structure of Hydroxyprogesterone Caproate Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hydroxyprogesterone Caproate Injection Distributors
11.3 Hydroxyprogesterone Caproate Injection Customer
12 World Forecast Review for Hydroxyprogesterone Caproate Injection by Geographic Region
12.1 Global Hydroxyprogesterone Caproate Injection Market Size Forecast by Region
12.1.1 Global Hydroxyprogesterone Caproate Injection Forecast by Region (2026-2031)
12.1.2 Global Hydroxyprogesterone Caproate Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hydroxyprogesterone Caproate Injection Forecast by Type (2026-2031)
12.7 Global Hydroxyprogesterone Caproate Injection Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 AMAG Pharmaceuticals
13.1.1 AMAG Pharmaceuticals Company Information
13.1.2 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AMAG Pharmaceuticals Main Business Overview
13.1.5 AMAG Pharmaceuticals Latest Developments
13.2 Mcguff Pharmaceuticals Inc
13.2.1 Mcguff Pharmaceuticals Inc Company Information
13.2.2 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mcguff Pharmaceuticals Inc Main Business Overview
13.2.5 Mcguff Pharmaceuticals Inc Latest Developments
13.3 Aspen Oss B.V
13.3.1 Aspen Oss B.V Company Information
13.3.2 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Aspen Oss B.V Main Business Overview
13.3.5 Aspen Oss B.V Latest Developments
13.4 American Regent, Inc.
13.4.1 American Regent, Inc. Company Information
13.4.2 American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 American Regent, Inc. Main Business Overview
13.4.5 American Regent, Inc. Latest Developments
13.5 Mylan Institutional
13.5.1 Mylan Institutional Company Information
13.5.2 Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Mylan Institutional Main Business Overview
13.5.5 Mylan Institutional Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂